CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock (DOREMI-2)

Overview

About this study

The purpose of this study is to determine if there is a meaningful benefit from the use of medications purported to increase the pumping function of the heart (i.e., inotropes) among critically ill patients admitted to the Cardiac Intensive Care Unit (CICU) at participating sites.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:
* Adult patients ≥ 18 years of age admitted to an intensive care unit
* SCAI class C or D cardiogenic shock

Exclusion Criteria:
* Unwilling or unable to obtain informed consent by the participant or substitute decision maker
* Patients who are currently pregnant or breast-feeding
* Patients presenting with an out-of-hospital cardiac arrest (OHCA)
* Administration of milrinone or dobutamine in the 24 hours preceding anticipated randomization
* Severe obstructive valvular lesions, including aortic stenosis and/or mitral stenosis
* Dynamic left ventricular outflow tract obstruction

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/6/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Benjamin Hibbert, M.D., Ph.D.

Open for enrollment

Contact information:

Sarah Devamani M.S.

(507) 255-0876

Devamani.Sarah@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20566876

Mayo Clinic Footer